Global Ankylosing Spondylitis Treatment Market Growth (Status and Outlook) 2023-2029

Global Ankylosing Spondylitis Treatment Market Growth (Status and Outlook) 2023-2029

Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years.

LPI (LP Information)' newest research report, the “Ankylosing Spondylitis Treatment Industry Forecast” looks at past sales and reviews total world Ankylosing Spondylitis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Ankylosing Spondylitis Treatment sales for 2023 through 2029. With Ankylosing Spondylitis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ankylosing Spondylitis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Ankylosing Spondylitis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ankylosing Spondylitis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ankylosing Spondylitis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ankylosing Spondylitis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ankylosing Spondylitis Treatment.

The global Ankylosing Spondylitis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.

This report presents a comprehensive overview, market shares, and growth opportunities of Ankylosing Spondylitis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics

Segmentation by application
Juveniles
Adults

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson

Please note: The report will take approximately 2 business days to prepare and deliver.